bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2025, Номер unknown
Опубликована: Май 21, 2025
Despite effective combination antiretroviral therapy (cART), chronic neuroinflammation and glial dysfunction continues to be an important yet understudied issue with people living HIV (PLWH). The endocannabinoid system is increasingly recognized as a potential therapeutic target for modulating neuroimmune environments, given its role in regulating synaptic plasticity, immune responses, neuroinflammatory cascades. However, the extent which cannabinoids influence HIV-associated remains unclear. This study investigates impact of Δ9-tetrahydrocannabinol (THC) on astrocyte growth characteristics, viability, senescence-associated cytokine release following exposure Tat protein using primary mixed cultures derived from rhesus macaques. Real-time impedance-based cellular integrity assessments were conducted xCELLigence system, while morphological analyses quantification performed phase-contrast microscopy multiplex immunoassays. Treatment macaques THC protected astrocytes virus-induced senescence. Further, facilitated rapid recovery Tat-induced decline adhesion, suggesting compensatory effect. promoted process elongation complexity, indicative shift toward neuroprotective phenotype. Furthermore, significantly reduced inflammatory secretion, including TNF-α, IL-6, IL-1β, apparently dose-dependent manner. These findings suggest that may modulate PLWH by promoting astrocytic survival, suppressing enhancing neurotrophic signaling. prolonged high-dose negatively survival. results underscore complexity cannabinoid signaling CNS highlight cannabinoid-based interventions mitigate neuroinflammation.
Язык: Английский